Prestige Consumer Healthcare Inc. (PBH) |
61 -1.79 (-2.85%) 10-10 16:00 |
Open: | 62.76 |
High: | 63.21 |
Low: | 60.77 |
Volume: | 365,153 |
Market Cap: | 3,002(M) |
PE Ratio: | 14.32 |
Exchange: | New York Stock Exchange |
Industry: | Medical - Distribution |
Sector: | Healthcare |
Technical analysis | ||||
![]() |
||||
sell | buy |
Resistance 2: | 66.04 |
Resistance 1: | 64.03 |
Pivot price: | 62.88 |
Support 1: | 60.77 |
Support 2: | 50.56 |
52w High: | 90.04 |
52w Low: | 60.77 |
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
EPS | 4.260 |
Book Value | 37.710 |
PEG Ratio | 0.00 |
Gross Profit | 12.959 |
Profit Margin (%) | 19.02 |
Operating Margin (%) | 28.76 |
Return on Assets (ttm) | 6.5 |
Return on Equity (ttm) | 12.1 |
Fri, 10 Oct 2025
Prestige Consumer Healthcare (NYSE:PBH) Receives Hold (C) Rating from Weiss Ratings - MarketBeat
Mon, 06 Oct 2025
Prestige Consumer Healthcare Inc. to Release Fiscal 2026 Second Quarter Earnings on November 6, 2025 - Quiver Quantitative
Mon, 06 Oct 2025
Prestige Consumer Healthcare to Release Fiscal 2026 Second Quarter Earnings Results - GlobeNewswire
Mon, 06 Oct 2025
Q2 Results Nov 6: Prestige Consumer Healthcare to Host Webcast and Conference Call - Stock Titan
Sun, 05 Oct 2025
Prestige Consumer Healthcare Inc. (NYSE:PBH) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Thu, 18 Sep 2025
Prestige Consumer Healthcare Inc. $PBH Shares Sold by Amundi - MarketBeat
![]() StockChart iOS |
![]() StoxlineLite iOS |
![]() StoxlineLite iOS |
![]() OptionCalc iOS |
![]() StockChart Android |
![]() StoxlineLite Android |
![]() StoxlinePro Android |
![]() OptionCalc Android |